4.3 Review

Efficacy and safety of perampanel in epilepsy: A systematic review and meta-analysis of randomised controlled trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Clinical Neurology

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study

T. Nishida et al.

ACTA NEUROLOGICA SCANDINAVICA (2018)

Article Clinical Neurology

Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data

Alexandra Rohracher et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)

Review Medicine, General & Internal

Rayyan-a web and mobile app for systematic reviews

Mourad Ouzzani et al.

SYSTEMATIC REVIEWS (2016)

Review Psychiatry

Psychosocial aspects of epilepsy: a wider approach

Marco Mula et al.

BJPSYCH OPEN (2016)

Article Clinical Neurology

First clinical experiences with perampanel-The Kork experience in 74 patients

Bernhard J. Steinhoff et al.

EPILEPSIA (2014)

Article Clinical Neurology

Tolerability and safety of perampanel: two randomized dose-escalation studies

G. L. Krauss et al.

ACTA NEUROLOGICA SCANDINAVICA (2012)

Article Clinical Neurology

Central nervous system adverse effects of new antiepileptic drugs - A meta-analysis of placebo-controlled studies

G. Zaccara et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)